Llwytho...
Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptors in Schizophrenia Treatment
The last two decades have witnessed a rise in the “NMDA receptor hypofunction” hypothesis for schizophrenia, a devastating disorder that affects around 1% of the population worldwide. A variety of presynaptic, postsynaptic and regulatory proteins involved in glutamatergic signaling have thus been pr...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Trends Neurosci |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530036/ https://ncbi.nlm.nih.gov/pubmed/26148747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tins.2015.06.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|